Ads
related to: COVID-19 Vaccine
Search results
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize ...
Benzinga· 5 days agoSanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID ...
AstraZeneca withdraws Covid-19 vaccine, citing plethora of other shots and low demand
ABC Action News Tampa Bay· 7 days agoAstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a...
Being vaccinated against COVID-19 reduces the severity of the illness
Digital Journal· 5 days agoA new study reveals how COVID-19 vaccines prevent severe disease. This is based on research...
AstraZeneca pulls its COVID-19 vaccine from the European market
Stamford Advocate· 6 days agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
AstraZeneca withdraws Covid-19 vaccine, citing low demand
WKBT La Crosse· 7 days agoAstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a...
AstraZeneca withdraws Covid-19 vaccine citing low demand - WTOP News
WTOP Washington· 7 days agoThe vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been...
COVID patient testing, isolation of sick staff cut in-hospital viral spread, modeling study suggests
Center for Infectious Disease Research and Policy· 8 hours agoThe study period spanned the predominance of different viral variants and the availability of...
AstraZeneca to withdraw its COVID-19 vaccine; says dip in demand is the reason
WSB Radio· 6 days agoThe Oxford-AstraZeneca COVID-19 vaccine is being withdrawn worldwide, according to the company. The...
AstraZeneca pulls its COVID-19 vaccine from the European market
Newsday· 7 days agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
Novavax Stock Doubles on $1.2B Sanofi Deal for COVID-19, Flu Vaccines
Investopedia· 5 days agoSanofi agreed to pay Novavax $500 million upfront, with another $700 million in possible payments...